Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Verde AgriTech Enters Exclusive Carbon Credit Partnership with UNDO
-
Abaxx Provides Q3 2025 Corporate Update
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Brady Corporation Reports Fiscal 2026 First Quarter Results and Raises the Low End of its Fiscal 2026 Adjusted Diluted EPS Guidance
-
Pop. Fizz. Feast. KFC Canada’s New Festive Fizz Joins Their Iconic Holiday Menu Lineup
-
Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment
-
J-Star Announces General Meeting of Shareholders
-
Cre8 Enterprise Limited Accepts Crypto-Currencies as a Payment Method for Its Clients
-
Save Up to 21% This Black Friday on TORRAS OrigArmor: The World’s First 3D Curved Anti-Reflective Screen Protector
-
SolarMax Technology Reports Third Quarter 2025 Financial Results
-
Luckin Coffee Announces Third Quarter 2025 Financial Results
-
AlorAir Showcases Comprehensive Clean Air Solutions at ISSA Show North America 2025
-
Validic Joins Digital Medicine Society Initiative to Advance Connected Health for Older Adults
-
Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy
-
The Vita Coco Company Issues Statement Regarding Tariff Relief
-
Mobix Labs Takes Action Against Denis Tse, ACE Equity Partners International, Asia-IO, and ACE SO4 to Recover Over $250 Million in Damages
-
Plug Power Selected by Carlton Power for 55 MW GenEco Electrolyzer Deployment Across Three Green Hydrogen Projects in the United Kingdom
-
Curbee Releases “The16” Report: The Case for Mobile Service
-
1inch launches Aqua: the first shared liquidity protocol, now available for developers
-
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
-
American Rebel Holdings, Inc. (NASDAQ: AREB) Continues American Rebel Light Beer Distribution Expansion with Wilson McGinley in Pennsylvania
-
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
-
Fortrea Appoints Agnieszka Gallagher as General Counsel
-
Aptera Motors Reports Third Quarter 2025 Financial Results
-
Signify share repurchase period update
-
Immatics Announces Third Quarter 2025 Financial Results and Business Update
-
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
-
Net Asset Value(s)
-
Tower Semiconductor and Switch Semiconductor Collaborate to Deliver Best-in-Class Efficiency for Next-Generation AI and Server Power Systems
-
EnviroGold Global Announces Positive ANDRITZ Case Study Confirming NVRO Process™ Commercial Readiness and Global Scalability
-
TransAlta to Acquire 310 MW Contracted Ontario Gas Portfolio for $95 Million
-
Auction result of Treasury Bills - RIKV 26 0318 - RIKV 26 0520
-
Codere Online Appoints Marcus Arildsson as Chief Financial Officer
-
LFTD Partners Inc. Reports Q3 2025 Basic EPS of $0.04
-
Allot to Participate in the 6th Annual Needham Tech Week Conference on November 24, 2025
-
Baltic Horizon Fund publishes its NAV for October 2025
-
H World Group Limited Reports Third Quarter of 2025 Unaudited Financial Results
-
Comstock Inc. to Participate in Water Tower Research Fireside Chat on Tuesday, November 18, 2025
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Plotly Dash Enterprise Named Finalist for InfoWorld Technology of the Year
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Pecoy Copper to Commence Drilling Activities Shortly
-
Radware Announces 2025 Annual General Meeting
-
FED Fitness Launches Black Friday Flash Deals: Up to 50% Off the Best in Home Gym Gear
-
Twin Hospitality Group to Acquire Eight Twin Peaks Franchise Locations in Florida
-
Phase One of Bitcoin Munari Presale Begins With $0.35 Initial Offering
-
High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
-
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advan
-
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

